ARTICLE | Company News
Covis, GlaxoSmithKline sales and marketing update
January 2, 2012 8:00 AM UTC
GlaxoSmithKline granted Covis U.S. and Puerto Rican rights to commercialize antibiotics Fortaz ceftazidime and Zinacef cefuroxime, cardiovascular drug Lanoxin digoxin, depression drug Parnate trany...